Read + Share
Camidge DR, Sugawara S, Kondo M, Kim HR, et al. Efficacy and safety of brigatinib in patients with ALK TKI-naive advanced ALK+
NSCLC: Integrated analysis of the ALTA-1L and J-ALTA trials. Lung Cancer 2025;201:108424.
PMID: 39923717
|
 |
|
Camidge DR, Sugawara S, Kondo M, Kim HR, et al. Efficacy and safety of brigatinib in patients with ALK TKI-naive advanced ALK+
NSCLC: Integrated analysis of the ALTA-1L and J-ALTA trials. Lung Cancer 2025;201:108424.
PMID: 39923717
|
|
|
|